Overview
IgG4-related pachymeningitis is a rare condition in which the thick outer membrane covering the brain and spinal cord (called the pachymeninges or dura mater) becomes inflamed and thickened. It is part of a broader group of conditions known as IgG4-related disease (IgG4-RD), where the immune system mistakenly causes inflammation and scarring in various organs. In this form, the inflammation specifically targets the protective coverings of the brain and spinal cord. The most common symptoms include persistent headaches, which can be severe, along with vision problems such as double vision or vision loss. Some patients experience numbness, weakness, or tingling in parts of the body, depending on which nerves are affected by the thickened membrane. Seizures and cranial nerve problems (affecting the face, eyes, or hearing) can also occur. The condition can mimic other serious diseases like cancer or infections, which sometimes delays diagnosis. Treatment typically involves medications that suppress the overactive immune response. Corticosteroids such as prednisone are usually the first-line treatment and often produce a good initial response. For patients who relapse or do not respond well to steroids, other immunosuppressive drugs like azathioprine, mycophenolate mofetil, or methotrexate may be used. Rituximab, a targeted therapy that depletes certain immune cells, has shown promise in difficult cases. Early diagnosis and treatment are important to prevent permanent nerve damage.
Also known as:
Key symptoms:
Persistent or severe headachesDouble vision or blurred visionVision lossFacial numbness or painHearing lossWeakness in arms or legsSeizuresDifficulty with balance or coordinationNumbness or tingling in the bodyDrooping eyelid or difficulty moving the eyesNeck stiffnessFatigueCognitive difficulties or confusionSwelling of other organs (salivary glands, pancreas, kidneys)
Clinical phenotype terms (39)— hover any for plain English
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for IgG4-related pachymeningitis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for IgG4-related pachymeningitis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to IgG4-related pachymeningitis.
Community
No community posts yet. Be the first to share your experience with IgG4-related pachymeningitis.
Start the conversation →Latest news about IgG4-related pachymeningitis
No recent news articles for IgG4-related pachymeningitis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How certain is the diagnosis, and do I need a biopsy to confirm it?,Are any other organs affected by IgG4-related disease in my case?,What is the plan for tapering steroids, and what steroid-sparing medication do you recommend?,How often will I need MRI scans and blood tests to monitor my condition?,What are the signs of a relapse that I should watch for?,Is rituximab an option for me if other treatments do not work well enough?,Are there any clinical trials or research studies I could participate in?
Common questions about IgG4-related pachymeningitis
What is IgG4-related pachymeningitis?
IgG4-related pachymeningitis is a rare condition in which the thick outer membrane covering the brain and spinal cord (called the pachymeninges or dura mater) becomes inflamed and thickened. It is part of a broader group of conditions known as IgG4-related disease (IgG4-RD), where the immune system mistakenly causes inflammation and scarring in various organs. In this form, the inflammation specifically targets the protective coverings of the brain and spinal cord. The most common symptoms include persistent headaches, which can be severe, along with vision problems such as double vision or v
How is IgG4-related pachymeningitis inherited?
IgG4-related pachymeningitis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does IgG4-related pachymeningitis typically begin?
Typical onset of IgG4-related pachymeningitis is adult. Age of onset can vary across affected individuals.
Which specialists treat IgG4-related pachymeningitis?
16 specialists and care centers treating IgG4-related pachymeningitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.